Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11595-11617
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11595
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11595
All individuals born in areas with high and intermediate HBV prevalence (> 2 % HBsAg positivity) including immigrants and adopted children |
Further subjects who belong to a high risk group and should generally be screened |
Individuals with elevated ALT/AST or others signs of liver disease |
Household and sexual contacts of HBsAg-positive persons |
Persons who have ever injected drugs |
Persons with multiple sexual partners or history of sexually transmitted disease |
Men who have sex with men |
Inmates of correctional facilities and jails |
Individuals infected with HCV or HIV |
Patients undergoing renal dialysis |
Patients undergoing chemotherapy or immunosuppressive therapy |
All pregnant women |
- Citation: Niederau C. Chronic hepatitis B in 2014: Great therapeutic progress, large diagnostic deficit. World J Gastroenterol 2014; 20(33): 11595-11617
- URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11595.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11595